Patents by Inventor Ales Gavenda

Ales Gavenda has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10188648
    Abstract: The present disclosure relates to solid state forms of Selexipag, in particular selexipag forms IV and V, and processes for preparation thereof, pharmaceutical compositions thereof, and methods of use thereof.
    Type: Grant
    Filed: September 2, 2016
    Date of Patent: January 29, 2019
    Assignee: TEVA PHARMACEUTICALS INTERNATIONAL GMBH
    Inventors: Nidia Villalva, Ivon Cante, Martin Aybar, Angel Rodriguez, Alejandro Guillen Torres, Hana Kantor, Ales Gavenda, Hugo Herrera, Alexander Jegorov, Nydia Lopez
  • Publication number: 20180214446
    Abstract: The present disclosure relates to solid state forms of Selexipag, in particular selexipag forms IV and V, and processes for preparation thereof, pharmaceutical compositions thereof, and methods of use thereof.
    Type: Application
    Filed: September 2, 2016
    Publication date: August 2, 2018
    Inventors: Nidia VILLALVA, Ivon CANTE, Martin AYBAR, Angel RODRIGUEZ, Alejandro Guillen TORRES, Hana KANTOR, Ales GAVENDA, Hugo HERRERA, Alexander JEGOROV, Nydia LOPEZ
  • Patent number: 9394266
    Abstract: The invention relates to solid state forms of Cabazitaxel and processes for preparing the solid state forms. The invention further relates to pharmaceutical compositions and formulations comprising one or more of the solid state forms.
    Type: Grant
    Filed: March 7, 2013
    Date of Patent: July 19, 2016
    Assignee: Ivax International GmBh
    Inventors: Pavel Vraspir, Alexandr Jegorov, Roman Gabriel, Ales Gavenda
  • Patent number: 9067915
    Abstract: Process for the preparation of sunitinib malate form I via sunitinib acetate and polymorphs of said intermediate.
    Type: Grant
    Filed: July 17, 2013
    Date of Patent: June 30, 2015
    Assignee: Teva Pharmaceutical Industries LTD.
    Inventors: Alexandr Jegorov, Ales Gavenda, Pavel Vraspir, Augusto Canavesi, Francesca Scarpitta
  • Publication number: 20150038564
    Abstract: The invention relates to solid state forms of Cabazitaxel and processes for preparing the solid state forms. The invention further relates to pharmaceutical compositions and formulations comprising one or more of the solid state forms.
    Type: Application
    Filed: March 7, 2013
    Publication date: February 5, 2015
    Inventors: Pavel Vraspir, Alexandr Jegorov, Roman Gabriel, Ales Gavenda
  • Patent number: 8618309
    Abstract: Process for the preparation of sunitinib malate form I via sunitinib acetate and polymorphs of said intermediate.
    Type: Grant
    Filed: July 23, 2009
    Date of Patent: December 31, 2013
    Assignee: Teva Pharmaceutical Industries Ltd.
    Inventors: Alexandr Jegorov, Ales Gavenda, Pavel Vraspir, Augusto Canavesi, Francesca Scarpitta
  • Publication number: 20130296575
    Abstract: Process for the preparation of sunitinib malate form I via sunitinib acetate and polymorphs of said intermediate.
    Type: Application
    Filed: July 17, 2013
    Publication date: November 7, 2013
    Inventors: Alexandr JEGOROV, Ales Gavenda, Pavel Vraspir, Augusto Canavesi, Francesca Scarpitta
  • Publication number: 20110118477
    Abstract: Process for the preparation of sunitinib malate form I via sunitinib acetate and polymorphs of said intermediate.
    Type: Application
    Filed: July 23, 2009
    Publication date: May 19, 2011
    Applicant: TEVA PHARMACEUTICAL INDUSTRIES LTD.
    Inventors: Alexandr Jegorov, Ales Gavenda, Pavel Vraspir, Augusto Canavesi, Francesca Scarpitta
  • Publication number: 20100256158
    Abstract: Provided is dasatinib, solvates thereof and their crystalline forms, methods for their preparation, and pharmaceutical compositions thereof.
    Type: Application
    Filed: June 14, 2010
    Publication date: October 7, 2010
    Inventors: Ondrej SIMO, Jirí Filipcik, Alexandr Martaus, Alexandr Jegorov, Ales Gavenda, Judith Aronhime, Pavel Vraspír, Tamás Koltai, Jirí Faustmann, Roman Gabriel
  • Publication number: 20100256392
    Abstract: The present invention provides polymorphs of Sunitinib base and processes for preparation thereof.
    Type: Application
    Filed: November 21, 2008
    Publication date: October 7, 2010
    Applicant: TEVA PHARMACEUTICAL INDUSTRIES LTD.
    Inventors: Ales Gavenda, Ettore Bigatti, Alexandr Jegorov, Augusto Canavesi, Pavel Vraspir, Judith Aronhime, Peter Lindsay MacDonald, Francesca Scarpitta, Marco Villa, Paolo Angioletti
  • Patent number: 7759481
    Abstract: The present invention provides novel crystalline forms of 5-deazacytidine, and pharmaceutical compositions comprising these novel forms. The invention also provides methods for the preparation of the novel forms and compositions.
    Type: Grant
    Filed: January 11, 2008
    Date of Patent: July 20, 2010
    Assignee: Ivax Corporation
    Inventors: Ales Gavenda, Alexandr Jegorov
  • Publication number: 20100004449
    Abstract: The preparation of crystalline Erlotinib base form G2 is described. This crystalline form can be converted to an Erlotinib salt, such as Erlotinib HCl, which can be used in the treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC).
    Type: Application
    Filed: July 7, 2009
    Publication date: January 7, 2010
    Applicant: PLUS CHEMICALS SA
    Inventors: Ales GAVENDA, Pavel VRASPIR, Augusto CANAVESI, Judith ARONHIME, Ettore BIGATTI, Jiri FAUSTMANN, Alexandr JEGOROV, Peter W. STEPHENS, Giovanna LUX, Maurizio PAIOCCHI
  • Publication number: 20090264438
    Abstract: Solvates and crystalline forms of imatinib mesylate are described. Further, methods for preparing such solvates and crystalline forms of imatinib mesylate are described.
    Type: Application
    Filed: April 17, 2008
    Publication date: October 22, 2009
    Inventors: Alexandr Jegorov, Miloslav Chudik, Judith Aronhime, Ales Gavenda, Jiri Faustmann
  • Publication number: 20090192200
    Abstract: Provided are sorafenib hemi-tosylate, polymorphs thereof, polymorphs of sorafenib tosylate, preparation thereof and pharmaceutical compositions thereof.
    Type: Application
    Filed: January 19, 2009
    Publication date: July 30, 2009
    Inventors: Ales Gavenda, Alexandr Jegorov, Pierluigi Rossetto, Peter Lindsay MacDonald, Augusto Canavesi
  • Publication number: 20090131665
    Abstract: The invention provides processes for preparing crystalline Forms A, B and pure crystalline Form A of Erlotinib hydrochloride.
    Type: Application
    Filed: August 25, 2008
    Publication date: May 21, 2009
    Inventors: Ales Gavenda, Jiri Faustmann, Augusto Canavesi, Dietmar Flubacher
  • Publication number: 20090124642
    Abstract: The invention provides a novel crystalline form of Erlotinib HCl, processes for its preparation, and formulations thereof.
    Type: Application
    Filed: August 25, 2008
    Publication date: May 14, 2009
    Inventors: Augusto Canavesi, Marco Villa, Ales Gavenda, Jiri Faustmann, Judith Aronhime, Ettore Gibatti, Alexandr Jegorov
  • Publication number: 20090118297
    Abstract: Provided is dasatinib, solvates thereof and their crystalline forms, methods for their preparation, and pharmaceutical compositions thereof.
    Type: Application
    Filed: October 23, 2008
    Publication date: May 7, 2009
    Inventors: Ondrej SIMO, Jiri Filipcik, Alexandr Martaus, Alexandr Jegorov, Ales Gavenda, Judith Aronhime, Pavel Vraspir, Tamas Koltai, Jiri Faustmann, Roman Gabriel
  • Publication number: 20090012295
    Abstract: The present invention provides amorphous erlotinib, processes for the preparation thereof, and processes to prepare additional forms of erlotinib.
    Type: Application
    Filed: June 25, 2008
    Publication date: January 8, 2009
    Inventors: Ales Gavenda, Augusto Canavesi, Dietmar Flubacher, Jiri Faustmann, Alexandr Jegorov
  • Publication number: 20080287378
    Abstract: The present invention provides novel crystalline forms of 5-deazacytidine, and pharmaceutical compositions comprising these novel forms. The invention also provides methods for the preparation of the novel forms and compositions.
    Type: Application
    Filed: January 11, 2008
    Publication date: November 20, 2008
    Inventors: Ales Gavenda, Alexandr Jegorov
  • Publication number: 20080090833
    Abstract: Solvates and crystalline forms of imatinib mesylate are described. Further, methods for preparing such solvates and crystalline forms of imatinib mesylate are described.
    Type: Application
    Filed: April 27, 2007
    Publication date: April 17, 2008
    Inventors: Alexandr Jegorov, Miloslav Chudik, Judith Aronhime, Ales Gavenda, Jiri Faustmann